Could this drug help spot early signs of psychosis? new study investigates
Knowledge-focused
Recruiting now
This study looks at whether a new drug called MT1988 can cause changes in thinking, symptoms, and other measures in people aged 17 to 30 who are at high risk for psychosis. Participants take the drug or a placebo twice daily for 8 weeks and complete regular tests. The goal is not…
Phase: PHASE1, PHASE2 • Sponsor: Monument Therapeutics Limited • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC